| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,650 | $30 | $396.1K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 32,700 | $10 | $359.7K |
| J3262 | Injection, tocilizumab, 1 mg | 16,960 | $10 | $84.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 700 | $100 | $67.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,440 | $30 | $63.4K |
| J0897 | Injection, denosumab, 1 mg | 1,800 | $20 | $32.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 480 | $60 | $26.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 70 | $130 | $9K |
| 96366 | The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease. | 140 | $20 | $2.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 20 | $140 | $2.2K |